Organotin(IV) compounds derived from ibuprofen and cinnamic acids, an alternative into design of anti-inflammatory by the cyclooxygenases (COX-1 and COX-2) pathway

被引:27
|
作者
Romero-Chavez, Maria M. [1 ]
Pineda-Urbina, Kayim [1 ]
Perez, David J. [2 ]
Obledo-Benicio, Fernando [1 ]
Flores-Parra, Angelina [3 ]
Gomez-Sandoval, Zeferino [1 ]
Ramos-Organillo, Angel [1 ]
机构
[1] Univ Colima, Fac Ciencias Quim, Km 9 Carr, Coquimatlan 28400, Colima, Mexico
[2] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2E1, Canada
[3] IPN, Ctr Invest & Estudios Avanzados, Dept Quim, Apartado Postal 14-740, Mexico City 07000, DF, Mexico
关键词
Stannoxanes; Ibuprofen; Coordination; DFT; Docking; Cyclooxygenase; VITRO ANTITUMOR-ACTIVITY; IN-VITRO; CRYSTAL-STRUCTURES; MOLECULAR DOCKING; SPECTROSCOPIC CHARACTERIZATION; DICARBOXYLIC-ACIDS; BASIS-SETS; COMPLEXES; DERIVATIVES; INHIBITORS;
D O I
10.1016/j.jorganchem.2018.02.049
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
New tributyl-, dibutyl-and diphenyl-tin(IV) complexes derived from ibuprofen and cinnamic acids were synthesized. All compounds were structurally characterized by FT-IR, multinuclear H-1, C-13, F-19 and Sn-119 NMR and corroborated by 2D spectra. The NMR data in CDCl3 revealed several hexacoordinated compounds with octahedral geometry. Moreover, in DMSO-d(6) some of these complexes switched to heptacoordination with a pentagonal-bipyramidal geometry due to the inclusion of a solvent's molecule; their Sn-119 signals moved up field by around 58 ppm compared to their chemical shifts in non-coordinated solvent CDCl3. The structural results were supported by Density Functional Theory (DFT) computational calculations. In addition, a docking study was performed to evaluate the ability of ligands to interact within the active site of cyclooxygenases (COX-1 and COX-2). Docking results showed a possible binding of stannoxanes theoretically more selective towards COX-2 than ibuprofen. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:58 / 70
页数:13
相关论文
共 50 条
  • [1] Anti-inflammatory strategies in hypertension: Focus on COX-1 and COX-2
    Hermann, M
    Enseleit, F
    Ruschitzka, FT
    CURRENT HYPERTENSION REPORTS, 2005, 7 (01) : 52 - 60
  • [2] Anti-inflammatory strategies in hypertension: Focus on COX-1 and COX-2
    Matthias Hermann
    Frank Enseleit
    Frank T. Ruschitzka
    Current Hypertension Reports, 2005, 7 : 52 - 60
  • [3] Gastric and cardiovascular effects of COX-1 and COX-2 selective nonsteroidal anti-inflammatory drugs
    Adami, M.
    Coppelli, G.
    Guaita, E.
    Giovannini, E.
    Coruzzi, G.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 58 - 58
  • [4] Umbelliferone β-D-galactopyranoside exerts an anti-inflammatory effect by attenuating COX-1 and COX-2
    Kumar, Vikas
    Al-Abbasi, F. A.
    Verma, Amita
    Mujeeb, Mohd
    Anwar, Firoz
    TOXICOLOGY RESEARCH, 2015, 4 (04) : 1072 - 1084
  • [5] COX-1/COX-2 inhibition assays and histopathological study of the new designed anti-inflammatory agent with a pyrazolopyrimidine core
    Abdelall, Eman K. A.
    Lamie, Phoebe F.
    Ahmed, Amira K. M.
    El-Nahass, El-Shaymaa
    BIOORGANIC CHEMISTRY, 2019, 86 : 235 - 253
  • [6] Design, synthesis of new anti-inflammatory agents with a pyrazole core: COX-1/COX-2 inhibition assays, anti-inflammatory, ulcerogenic, histopathological, molecular Modeling, and ADME studies
    Abdellatif, Khaled R. A.
    Abdelall, Eman K. A.
    Elshemy, Heba A. H.
    Lamie, Phoebe F.
    Elnahaas, Elshaymaa
    Amin, Dina M. E.
    JOURNAL OF MOLECULAR STRUCTURE, 2021, 1240
  • [7] Compounds from the insect Blaps japanensis with COX-1 and COX-2 inhibitory activities
    Yan, Yong-Ming
    Li, Li-Ji
    Qin, Xiao-Chu
    Lu, Qing
    Tu, Zheng-Chao
    Cheng, Yong-Xian
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (12) : 2469 - 2472
  • [8] Perspective assessment of COX-1 and COX-2 selectivity of nonsteroidal anti-inflammatory drugs from clinical practice: Use of genetic function approximation
    Zambre, Ajit P.
    Ganure, Ashok L.
    Shinde, Devanand B.
    Kulkarni, Vithal M.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2007, 47 (02) : 635 - 643
  • [9] Design, synthesis, anti-inflammatory antitumor activities, molecular modeling and molecular dynamics simulations of potential naprosyn® analogs as COX-1 and/or COX-2 inhibitors
    El Sayed, Mardia T.
    El-Sharief, Marwa A. M. Sh.
    Zarie, Eman S.
    Morsy, Nesrin M.
    Elsheakh, Ahmed R.
    Nayel, Mohammed
    Voronkov, Andrey
    Berishvili, Vladimir
    Sabry, Nermien M.
    Hassan, Ghada S.
    Abdel-Aziz, Hatem A.
    BIOORGANIC CHEMISTRY, 2018, 76 : 188 - 201
  • [10] Design of balanced COX inhibitors based on anti-inflammatory and/or COX-2 inhibitory ascidian metabolites
    Ju, Zhiran
    Su, Mingzhi
    Hong, Jongki
    Kim, Eun La
    Moon, Hyung Ryong
    Chung, Hae Young
    Kim, Suhkmann
    Jung, Jee H.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 180 : 86 - 98